Insights from 2023 ASCO® Annual Meeting
P

ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III Randomized Trial - Nine-Weeks vs. One-Year Trastuzumab for Early-Stage HER2+ BC"

By Insights from 2023 ASCO® Annual Meeting FEATURING Pierfranco Conte
June 15, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

15:54
Novartis Oncology

NCCN Category 1 Update: An Expert’s Perspective on First-Line Treatm…

Feat. J. Cohen

Featured Video

13:03
Novartis Oncology

CDK4/6 Inhibitor Option for HR+/HER2- mBC: Are All CDK4/6 Inhibitors…

Feat. D. Slamon

Related Content

AUTOPLAY
28:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri
17:39
Yale School of Medicine

2023 Menopause Update

Feat. M. Minkin
49:07
SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo
04:28
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …

Feat. S. Tolaney
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
50:59
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Early Stage Breast Cancer"

Feat. S. Tolaney, H. Rugo
07:50
Oncology Data Advisor

ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, &a…

Feat. K. Kalinsky
53:42
PleXus Communications

Managing Woman's Health in Menopause: Evolving Approaches for t…

Feat. J. Simon, T. Iyer, A. Fiffick, M. Minkin
30:46
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo
20:42
Total Health

2022 Updates in TNBC

Feat. I. Schlam
18:49
Yale School of Medicine

Menopause and Hot Flashes: What Medications are Available?

Feat. M. Minkin
03:05
ecancer

ASCO® 2023 Insights: "Phase III NATALEE Trial - Ribociclib + ET…

Feat. D. Slamon
05:45
SABCS 2022 Conference Coverage

SABCS 2022 Adjuvant Paclitaxel & Trastuzumab for Node- HER2+ BC:…

Feat. S. Tolaney
08:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Utility of Ki67 in Guiding Adjuvant Abema…

Feat. R. Patel
03:32
UCSF School of Medicine

Management of Abemaciclib-Related Diarrhea in HR+/HER2- eBC

Feat. S. Donahue
22:29
ESMO 2022 Conference Coverage

ESMO 2022 on Adjuvant Endocrine Therapy for BC: Who Needs More Than …

Feat. E. de Azambuja
07:34
PrecisCa

Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Anal…

Feat. M. Pegram
09:14
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Omission of Breast Surgery After Neoadjuva…

Feat. H. Kuerer
03:36
ecancer

ESMO 2023 Insights: "Phase 3 TROPION-Breast01 Trial - Datopotam…

Feat. A. Bardia